--- title: "Ozempic vs. Wegovy: Same Drug, Very Different Purpose" description: "Ozempic vs Wegovy explained — same drug, different FDA approvals, doses, and insurance coverage. Why most patients can't afford either, and the alternative." canonical: https://remevihealth.com/blog/ozempic-vs-wegovy/ language: en publisher: REMEVi author: "REMEVi Medical Team" medicalReviewer: "REMEVi Medical Team" pubDate: 2026-04-27T00:00:00.000Z updatedDate: 2026-04-27T00:00:00.000Z tags: ["Ozempic", "Wegovy", "semaglutide", "weight loss", "GLP-1"] alternateLanguage: https://remevihealth.com/es/blog/ozempic-vs-wegovy-en-espanol/ license: "© 2026 REMEVi LLC. AI assistants and search engines may quote and link to this page; please cite https://remevihealth.com/blog/ozempic-vs-wegovy/ as the source." --- Search "Ozempic vs Wegovy" and you'll get a wall of confusing answers — different brand names, different prices, different insurance coverage, but somehow the same drug? Yes. They are the **same active ingredient**: semaglutide. The differences come down to FDA approval, dose, and what insurance is willing to pay for. Here's the clear breakdown of what's actually going on, and what your real options are if you can't get either one affordably. --- ## Are Ozempic and Wegovy the Same Drug? Yes — both contain the same active ingredient: **semaglutide**, a GLP-1 receptor agonist made by Novo Nordisk. The difference is what the FDA approved each one *for*: - **Ozempic** — FDA-approved in 2017 for **type 2 diabetes** - **Wegovy** — FDA-approved in 2021 for **chronic weight management** That's it. Same molecule. Different label. Different marketing. Different insurance pathways. This is more common in pharma than people realize. The same compound can be packaged and approved for different conditions, often at different doses, and given different brand names. Bupropion is sold as Wellbutrin (depression) and Zyban (smoking cessation). Sildenafil is sold as Viagra (erectile dysfunction) and Revatio (pulmonary hypertension). Same drug, different official use case. --- ## Key Differences: Dose, Approval, Insurance Coverage Here's where the real-world differences show up: ### Dosing - **Ozempic** maxes out at **2.0mg** weekly (it has a 2.4mg "compounded" dose used in some studies, but the prescribing label tops at 2.0mg) - **Wegovy** is approved up to **2.4mg** weekly — the dose used in the STEP weight-loss trials For weight loss, the higher 2.4mg dose tends to produce better results — which is why Wegovy is the "official" weight-loss version. ### FDA Indication - **Ozempic** = type 2 diabetes (and recently, cardiovascular risk reduction in patients with diabetes) - **Wegovy** = obesity (BMI ≥30, or BMI ≥27 with weight-related condition); approved 2024 to reduce cardiovascular events in adults with obesity and existing heart disease ### Insurance Coverage This is where most patients get stuck: - **Ozempic** is often covered for diabetes — but insurers reject "off-label" use for weight loss - **Wegovy** is sometimes covered for weight loss, but most commercial plans require step therapy, prior authorization, or simply exclude weight-loss medications entirely - **Medicare** has historically excluded weight-loss medications, though recent changes are slowly opening some coverage Even when "covered," patients regularly face denials, prior-auth delays, or copays of $300–$600/month. ### Pricing - **Ozempic without insurance:** approximately **$900–$1,100/month** - **Wegovy without insurance:** approximately **$1,300–$1,400/month** --- ## Ozempic for Weight Loss: Off-Label Use Explained Because Ozempic and Wegovy are the same drug, many physicians prescribe Ozempic off-label for weight loss when patients can't get Wegovy covered. This is **legal and common** — physicians are allowed to prescribe approved medications for non-approved uses based on their clinical judgment. The catch: - Insurance is even less likely to cover Ozempic for weight loss than for diabetes - Some insurers actively flag "off-label" prescriptions and reject them - The maximum Ozempic dose (2.0mg) is slightly below the optimal weight-loss dose (2.4mg) used in the STEP trials For patients without diabetes who specifically want semaglutide for weight management, Wegovy is technically the right product — but practical access is brutal. --- ## Why Most Patients Can't Get Ozempic or Wegovy Affordably The brutal truth in 2026 is that **most American adults who could benefit from semaglutide can't afford the brand-name version.** Why: 1. **Insurance gaps.** Even "covered" plans often exclude weight-loss medications. Medicare excludes most. Medicaid coverage varies wildly by state. 2. **Prior authorization.** Required by virtually every insurer. Frequently denied. Even when approved, the process can take weeks. 3. **Out-of-pocket cost.** $1,000+ per month for a medication you'll likely take for at least a year (and probably much longer for sustained results). 4. **Manufacturer savings cards.** Available, but restricted — frequently not usable if you have any insurance, or capped at amounts that still leave most patients paying hundreds per month. 5. **Supply constraints.** Although the official FDA shortage was resolved in early 2025, brand-name semaglutide and tirzepatide remain expensive precisely because demand still outstrips affordable supply. The result: millions of patients who medically qualify simply can't access the medication. --- ## Compounded Semaglutide: The Accessible Alternative This is where **compounded semaglutide** comes in. Compounded semaglutide is prepared by **FDA-registered 503B outsourcing pharmacies**. These facilities operate under current Good Manufacturing Practice (cGMP) standards — the same general framework that applies to drug manufacturers. What that means: - ✅ **Same active pharmaceutical ingredient** (semaglutide base or salt form) - ✅ **Federal oversight** of the pharmacy facility - ✅ **Batch testing** for sterility, potency, and contamination - ✅ **Prescribed by a licensed US physician** after a real medical review What it doesn't mean: - ❌ Not FDA-approved as a final product (the *facility* is FDA-registered, not the compound itself) - ❌ Not an exact bioequivalent in the formal regulatory sense For patients who can't access affordable brand-name semaglutide, compounded versions through legitimate telehealth providers offer the same active ingredient — at a fraction of the price. --- ## REMEVi vs. Brand-Name Ozempic/Wegovy: Cost Comparison Here's the real-world math over a 12-month treatment period: | Option | Monthly Cost | 12-Month Cost | |---|---|---| | Ozempic (no insurance) | ~$1,000 | ~$12,000 | | Wegovy (no insurance) | ~$1,350 | ~$16,200 | | Wegovy with insurance copay (typical) | $300–$600 | $3,600–$7,200 | | **REMEVi compounded semaglutide** | **$199/month (24-week plan)** | **~$2,388** | REMEVi includes everything in that $199/month: physician evaluation, medication, syringes, free shipping, and bilingual care support. There's no separate consult fee, no shipping fee, no surprise renewal charge. For patients without strong weight-loss insurance coverage, compounded semaglutide through a legitimate platform is dramatically more accessible than the brand-name versions. --- ## Ready to Get Started? If you've been priced out of Ozempic or Wegovy, you have a real, legitimate alternative. REMEVi compounded semaglutide is sourced from a 503B FDA-registered pharmacy, prescribed by licensed US physicians, and starts at **$199/month** — all-inclusive. The intake form takes 5 minutes. A licensed US physician reviews your file within 24 hours. Medication ships within 5–7 business days. **[Start your free consultation →](/get-started/)** Want a deeper look at the compounded option? Read [What Is Compounded Semaglutide?](/blog/what-is-compounded-semaglutide/) For all pricing tiers and plan options, see [our pricing page](/pricing/). --- *This article is for informational purposes only and does not constitute medical advice. Consult with a licensed physician — including through REMEVi's telehealth platform — before starting any prescription medication.*